LDJ: Enzyme Immunoassay, Cannabinoids

Product code LDJ, “Enzyme Immunoassay, Cannabinoids” in FDA's classification database, is a Class II device type under 21 CFR 862.3870 (cannabinoid test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 150 clearances under LDJ, 21 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LDJ
Regulation
21 CFR 862.3870
Class
II
Panel
Clinical Toxicology
Clearances
150
Most recent
Jan 17, 2024
Third-party review
Eligible
Implant
No

What it covers

A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds include delta-9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use.

The identification in 21 CFR 862.3870, cannabinoid test system. FDA gives LDJ no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K232732Rapid Marijuana (THC) Test Strip 20, Rapid Marijuana (THC) Test Dipcard 20, Rapid Marijuana (THC) Test Strip 50, Rapid Marijuana (THC) Test Dipcard 50Co-Innovation Biotech Co., Ltd.Jan 17, 2024Traditional
K232604LYHER® Urine Marijuana (THC) Test Kit (Strip), LYHER® Urine Marijuana (THC) Test Kit (Cassette)Hangzhou Laihe Biotech Co., Ltd.Jan 10, 2024Traditional
K223162Healgen® Accurate Oral Fluid Drug Test, Healgen® Accurate Oral Fluid Drug Test COTHealgen Scientific,, LLCMar 17, 2023Traditional
K192515BIOEASY Marijuana Test Dip Card 40, BIOEASY Marijuana Test Dip Card 20, BIOEASY Marijuana Test Strip 40, BIOEASY Marijuana Test Strip 20Shenzhen Bioeasy Biotechnology Co., Ltd.Oct 11, 2019Traditional
K153741CLUNGENE Methamphetamine Test, CLUNGENE Morphine Test, CLUNGENE Marijuana TestHangzhou Clongene Biotech Co., Ltd.Mar 18, 2016Traditional
K152643EGENS Urine Test Cup THC-MDMA, EGENS Urine Test DipCard THC-MDMA, EGENS Urine Test Cassette MarijuanaNantong Egens Biotech Co., Ltd.Nov 2, 2015Traditional
K151203Immunalysis Cannabinoids Urine Enzyme Immunoassay, Immunalysis cTHC Urine Calibrators, Immunalysis cTHC Urine Control SetImmunalysis CorporationJun 5, 2015Traditional
K141320LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators and LZI Oral Fluid Cannabinoids ControlsLin-Zhi International, Inc.May 28, 2015Traditional
K142408FaStep Marijuana Tests (Strip, Panel Dip, Quick Cup, Turn-Key Split Cup), FaStep Methamphetamine Tests (Strip, Panel Dip, Quick Cup, Turn-Key Split Cup)Polymed Therapeutics, Inc.Sep 25, 2014Traditional
K140546HEALGEN THC ONE STEP MARIJUANA TEST , HEALGEN MAMP ONE STEP METHAMPHETAMINE TESTHealgen Scientific,, LLCJun 6, 2014Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 150 with a free account)

Clearances by year

21 LDJ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
20242134
20231161
2019128
2016181
2015348
2014261
20133162
20124193
20114219

Who submits

18 applicants cleared a LDJ device since 2011. 71% of the clearances went to applicants in United States, then China (24%) and United Kingdom (5%). By type: Traditional 100%.

ApplicantClearances since 2011
Guangzhou Wondfo Biotech Co., Ltd.2
Healgen Scientific,, LLC2
Lin-Zhi International, Inc.2
Biophor Diagnostics, Inc.1
Branan Medical Corp.1
Co-Innovation Biotech Co., Ltd.1
Hangzhou Clongene Biotech Co., Ltd.1
Hangzhou Laihe Biotech Co., Ltd.1

How FDA classifies it

Class II (special controls). A cannabinoid test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.

From 21 CFR 862.3870. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 862.3870 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LDJ clearances declared.

Ask about LDJ

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LDJ

What is FDA product code LDJ?

Product code LDJ, “Enzyme Immunoassay, Cannabinoids” in FDA's classification database, is a Class II device type under 21 CFR 862.3870 (cannabinoid test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 150 clearances under LDJ, 21 of them since 2011.

How many 510(k) clearances are there under LDJ?

FDA’s 510(k) database listed 150 clearances under LDJ as of Oct 29, 2026, 21 of them decided since 2011; the most recent decision was Jan 17, 2024. The Predicate Finder searches the live database.

Which companies have the most LDJ clearances?

Since 2011: Guangzhou Wondfo Biotech Co., Ltd. (2), Healgen Scientific,, LLC (2), Lin-Zhi International, Inc. (2), Biophor Diagnostics, Inc. (1) and Branan Medical Corp. (1). 18 applicants have cleared a LDJ device in that time.

Sources

  1. FDA product classification: LDJ · Product Classification database
  2. 21 CFR 862.3870: Cannabinoid test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LDJ · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LDJGet an email when FDA clears, recalls or publishes guidance for LDJ devices.

Know what FDA already cleared.